Michael J. Fox Foundation for Parkinson's Research

Academic/HospitalWebsite ↗

Also known as: Fox (Michael J.) Foundation for Parkinson's Research | Ken Marek, MD | Michael J. Fox Foundation for Parkinson's Research | The Michael J. Fox Foundation for Parkinson's Research

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Apr 1, 2006

Last known activity

Oct 31, 2025

Timeline

2000s

Jan 1, 2000
Michael J. Fox Foundation for Parkinson's Research— Founded

Drugs by trial phase (45 distinct, 48 trials)

Phase 4 (3 own, 0 via acquisition)

Phase 3 (8 own, 0 via acquisition)

Phase 2 (27 own, 0 via acquisition)

Phase 1 (6 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

ketamine

Indications

Studied for

Recent trials (49)

NCT07142044CollaboratorPhase 1/Phase 2Oct 31, 2025
NCT07207057CollaboratorPhase 3Sep 12, 2025
NCT07020026Lead sponsorPhase 2May 12, 2025
NCT06289582CollaboratorEarly Phase 1Aug 14, 2024
NCT06493045CollaboratorPhase 1May 16, 2024
NCT06309147CollaboratorPhase 1Mar 15, 2024
NCT07265596Lead sponsorPhase 2Oct 30, 2023
NCT05950906CollaboratorPhase 1Jun 27, 2023
NCT05817643CollaboratorPhase 1Jan 10, 2023
NCT05148884CollaboratorPhase 2Nov 9, 2021
NCT04944017CollaboratorN/AAug 31, 2021
NCT04906590Lead sponsorPhase 2Aug 30, 2021
NCT04810104CollaboratorPhase 2Apr 30, 2021
NCT04506073CollaboratorPhase 2Nov 9, 2020
NCT04551040CollaboratorPhase 1Nov 1, 2020

Details

Founded: New York City, NY, US Jan 1, 2000
Last known activity: Oct 31, 2025